Equity (Tables)

9 Months Ended

Sep. 30, 2022

Stockholders' Equity Note [Abstract]

Schedule of stock option activity

	Number of Options (in Shares)		Weighted Average Exercise Price
Outstanding, January 1, 2022		1,656,000	$	2.00
Granted		-	$	-
Exercised		-		-
Forfeited or cancelled		-		-
Outstanding, September 30, 2022		1,656,000	$	2.00
Exercisable, September 30, 2022		1,656,000	$	2.00

Schedule of warrants

	Number of Warrants (in Shares)			Weighted Average Exercise Price
Outstanding, January 1, 2022		5,926,763		$	*
Granted		-			-
Exercised		(418,931	)		-
Outstanding, September 30, 2022		5,507,832		$	-

	Number of Restricted Stock Shares		Weighted Average Grant Date Fair Value
Outstanding, January 1, 2022		1,000,000	$	0.48
Granted		-		-
Vested		1,000,000		0.40
Unvested, September 30, 2022		-	$	-

Schedule of share derivative liabilities

	September 30, 2022
Warrants	$	38
Stock options		6
RSUs vested but unissued		1
Total share derivative liability	$	45

Schedule of reverse stock split balance sheet

			Proforma
	As stated		Effect
Balance Sheet
Common stock:
Shares Issued:
9/30/2022		736,609,855		736,610
9/30/2021		145,713,591		145,714
Shares Outstanding:
9/30/2022		736,534,476		736,534
9/30/2021		145,638,212		145,638
Treasury Stock:		75,379		75

Schedule of reverse stock split EPS

		Three months ended September 30,						Nine months ended September 30,
EPS		2022			2021			2022			2021
Weighted Average Shares
Outstanding - basic and diluted	As stated		500,173,946			159,448,204			318,558,213			131,863,780
	Proforma		573,174			159,448			318,558			131,864
Net income (loss) per share:
Continuing operations	As stated		0.0001			(0.0370	)		(0.0310	)		(0.2620	)
	Proforma		0.1000			(37.00	)		(31.00	)		(262.00	)
Discontinued Operations	As stated		(0.002	)		0.0070			(0.0030	)		0.0400
	Proforma		(2.00	)		7.00			(3.00	)		40.00